104 related articles for article (PubMed ID: 3964674)
1. Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro.
Auclair C; Dugué B; Meunier B; Paoletti C
Biochemistry; 1986 Mar; 25(6):1240-5. PubMed ID: 3964674
[TBL] [Abstract][Full Text] [Related]
2. Accessibility to bacterial nucleic acids of the intercalating drug aliphatic amino acid ellipticinium derivatives in Escherichia coli and Salmonella typhimurium.
Banoun H; Le Bret M; Auclair C
Biochemistry; 1985 Jan; 24(3):701-7. PubMed ID: 3888261
[TBL] [Abstract][Full Text] [Related]
3. Peroxidase-catalyzed O-demethylation reactions. Quinone-imine formation from 9-methoxyellipticine derivatives.
Meunier G; Meunier B
J Biol Chem; 1985 Sep; 260(19):10576-82. PubMed ID: 4030757
[TBL] [Abstract][Full Text] [Related]
4. Peroxidase-catalysed oxidation of N2,N6-dimethyl-9-hydroxyellipticinium acetate. Evidence for the formation of an electrophilic quinone-iminium derivative.
Meunier G; Bernadou J; Meunier B
Biochem Pharmacol; 1987 Aug; 36(16):2599-604. PubMed ID: 3606658
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
Auclair C; Paoletti C
J Med Chem; 1981 Mar; 24(3):289-95. PubMed ID: 7265115
[TBL] [Abstract][Full Text] [Related]
6. Drug-DNA interactions: spectroscopic and footprinting studies of site and sequence specificity of elliptinium.
Mauffret O; Rene B; Convert O; Monnot M; Lescot E; Fermandjian S
Biopolymers; 1991 Oct; 31(11):1325-41. PubMed ID: 1777583
[TBL] [Abstract][Full Text] [Related]
7. Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.
Auclair C; Voisin E; Banoun H; Paoletti C; Bernadou J; Meunier B
J Med Chem; 1984 Sep; 27(9):1161-6. PubMed ID: 6471070
[TBL] [Abstract][Full Text] [Related]
8. omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
Bernadou J; Meunier G; Paoletti C; Meunier B
J Med Chem; 1983 Apr; 26(4):574-9. PubMed ID: 6834391
[TBL] [Abstract][Full Text] [Related]
9. Covalent binding of the antitumor agent N2-methyl-9-hydroxy-ellipticinium acetate (NSC 264137) on RNA and poly A in vitro.
Dugue B; Paoletti C; Meunier B
Biochem Biophys Res Commun; 1984 Oct; 124(2):416-22. PubMed ID: 6388575
[TBL] [Abstract][Full Text] [Related]
10. Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites.
Bernadou J; Monsarrat B; Roche H; Armand JP; Paoletti C; Meunier B
Cancer Chemother Pharmacol; 1985; 15(1):63-5. PubMed ID: 4006051
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin-catalyzed transformation of elliptinium acetate into electrophilic species. Evidences for oxidative activation of the drug in human red blood cells.
Ha T; Bernadou J; Voisin E; Auclair C; Meunier B
Chem Biol Interact; 1988; 65(1):73-84. PubMed ID: 3345574
[TBL] [Abstract][Full Text] [Related]
12. Covalent binding of elliptinium acetate (NSC 264137) to nucleic acids of L1210 cells in culture.
Dugue B; Auclair C; Meunier B
Cancer Res; 1986 Aug; 46(8):3828-33. PubMed ID: 2425935
[TBL] [Abstract][Full Text] [Related]
13. [Demonstration of the O-demethylation reaction catalyzed by a peroxidase: application to 9-methoxyellipticine].
Meunier G; Paoletti C; Meunier B
C R Acad Sci III; 1984; 299(15):629-32. PubMed ID: 6440666
[TBL] [Abstract][Full Text] [Related]
14. Peroxidase-catalysed covalent binding of the antitumor drug 2N-methyl-9-hydroxy-ellipticine to proteins.
Auclair C; Meunier B; Paoletti C
Biochem Pharmacol; 1983 Dec; 32(24):3883-6. PubMed ID: 6661265
[No Abstract] [Full Text] [Related]
15. Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
Bernadou J; Meunier B; Meunier G; Auclair C; Paoletti C
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1297-301. PubMed ID: 6584882
[TBL] [Abstract][Full Text] [Related]
16. Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile.
Maftouh M; Monsarrat B; Rao RC; Meunier B; Paoletti C
Drug Metab Dispos; 1984; 12(1):111-9. PubMed ID: 6141901
[TBL] [Abstract][Full Text] [Related]
17. Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells.
Larsen AK; Paoletti J; Belehradek J; Paoletti C
Cancer Res; 1986 Oct; 46(10):5236-40. PubMed ID: 3756875
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of drug-DNA interactions: a comparative temperature jump study of ellipticinium and 9-hydroxy ellipticinium.
Schwaller MA; Aubard J; Dodin G
J Biomol Struct Dyn; 1988 Dec; 6(3):443-58. PubMed ID: 3271531
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the peroxidase-derived metabolite of mitoxantrone with nucleic acids. Evidence for covalent binding of 14C-labeled drug.
Reszka K; Hartley JA; Kolodziejczyk P; Lown JW
Biochem Pharmacol; 1989 Dec; 38(23):4253-60. PubMed ID: 2597197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
